Implications of growth factor alterations in the treatment of pancreatic cancer

Autor: Malfertheiner Peter, Nitsche Barbara, Juhász Márk, Ebert Matthias PA

Publikováno v: Molecular Cancer, Vol 2, Iss 1, p 5 (2003)

Abstract Pancreatic cancer ranks fifth as a cause of cancer-related death in the world with an overall 5-year survival rate of less than 1% and a median survival of less than a year after tumour detection. Most of these patients have already metastas

Externí odkaz: https://doaj.org/article/9762f5e9c8ab44d2bcfd4b181c3ccc6c

Implications of growth factor alterations in the treatment of pancreatic cancer

Autor: Malfertheiner Peter, Nitsche Barbara, Juhász Márk, Ebert Matthias PA

Publikováno v: Molecular Cancer
Molecular Cancer, Vol 2, Iss 1, p 5 (2003)

Pancreatic cancer ranks fifth as a cause of cancer-related death in the world with an overall 5-year survival rate of less than 1% and a median survival of less than a year after tumour detection. Most of these patients have already metastases at the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::108d6349e0c291a98434332a52ca7082
https://pubmed.ncbi.nlm.nih.gov/12537586

Auditory Evoked Potentials Compared With Bispectral Index for Monitoring of Midazolam and Propofol Sedation During Colonoscopy.

Autor: von Delius, Stefan, Thies, Philipp, Rieder, Thomas, Wagenpfeil, Stefan, Herberich, Esther, Karagianni, Artemisia, Frimberger, Eckart, Meining, Alexander, Ludwig, Leopold, Ebert, Matthias PA, Schulte-Frohlinde, Ewert, Neu, Bruno, Prinz, Christian, Schmid, Roland M, Huber, Wolfgang

Publikováno v: American Journal of Gastroenterology (Springer Nature); Feb2009, Vol. 104 Issue 2, p318-325, 8p, 2 Charts, 2 Graphs

Helicobacter pylori and molecular mechanisms of gastric carcinogenesis: targets for prevention and therapy

Autor: Juhász, Márk, Herszényi, László, Tulassay, Zsolt, Malfertheiner, Peter, Ebert, Matthias PA

Publikováno v: Expert Review of Anticancer Therapy; February 2004, Vol. 4 Issue: 1 p97-103, 7p

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation.

Autor: Link F; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Li Y; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Zhao J; INRIA de Saclay, Palaiseau, France.; IfADo, Dortmund, Germany., Munker S; Department of Medicine II, University Hospital, LMU, Munich, Germany.; Liver Center Munich, University Hospital, LMU, Munich, Germany., Fan W; Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, People's Republic of China., Nwosu ZC; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA., Yao Y; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Wang S; Beijing Institute of Hepatology, Beijing You'an Hospital, Capital Medical University, Beijing, People's Republic of China., Huang C; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Department of Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China., Liebe R; Clinic of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke-University, Magdeburg, Germany., Hammad S; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Liu H; Department of Pathology, Beijing You'an Hospital, Affiliated with Capital Medical University, Beijing, People's Republic of China., Shao C; Department of Pathology, Beijing You'an Hospital, Affiliated with Capital Medical University, Beijing, People's Republic of China., Gao C; Department of Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China., Sun B; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, People's Republic of China., Török NJ; Gastroenterology and Hepatology, Stanford University, Palo Alto, CA, USA., Ding H; Department of Gastroenterology and Hepatology, Beijing You'an Hospital, Affiliated with Capital Medical University, Beijing, People's Republic of China., Ebert MP; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center, Mannheim, Germany., Weng H; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Ten Dijke P; Oncode Institute and Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., Drasdo D; INRIA de Saclay, Palaiseau, France.; IfADo, Dortmund, Germany., Dooley S; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany sai.wang@medma.uni-heidelberg.de steven.dooley@medma.uni-heidelberg.de., Wang S; Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany sai.wang@medma.uni-heidelberg.de steven.dooley@medma.uni-heidelberg.de.

Publikováno v: Gut [Gut] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.